Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Minority Barrier in Luxembourg
Total 0 results
Nothing found
Sponsors and Collaborators
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Cracow
Sahar Ahmed Abdalbary
University of Illinois Sickle Cell Patient Council
Chilgok Kyungpook National University
Norwegian Centre for Ageing and Health
Freed Study Group
Nakamura Memorial Hospital
American Osteopathic Association
Jennifer Jones
Beingmate Baby & Child Food Co Ltd .
European Organisation for Research and Treatment of Cancer
Haematology-Oncology
Calcivis Ltd
Centro OWLiver
Aaron R. Mangold
Comed B.V.
Abidi Pharmaceuticals
Jingzhou Central Hospital
William Carson
Fresenius Medical Care North America
View Full List
Medical Conditions
Progesterone Receptor Negative (PR-Negative) Breast Cancer
Patent Foramen Ovale
Narrow Implant
Neoplasms, Neck
Serum Bank
Smokers
Other Conditions for Which Risankizumab is an FDA-approved Treatment
Hernia, Paraesophageal
Pterygia
Hyperkalaemia Requiring Postoperative Dialysis
Periprocedural Myocardial Damage
Glucose Metabolism Disorders (Including Diabetes Mellitus)
Dupuytren Contracture
Head and Neck Carcinoma, Squamous Cell
COVID-19 Post Operative Complications
Closed Fracture of the Proximal Humerus
Child Disruptive Behavior Disorders
Caloric Deficit
Class II Caries in Premolars
Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v8
View Full List
Drug Interventions
Docetaxel
BI 695501
Apatinib
RBD1016
CPX-POM - 120 mg/m^2
Interleukin-2 (Proleukin)
Levofloxacin
Taxotere
Carboplatin
OPC-249
Iron-III Isomaltoside 1000
Midazolam (Part B)
Basal insulin
20-hydroxyecdysone Oral
Treatment D: Doravirine 150 mg tablet (50% drug loaded granule)
Tacrolimus 0.03% ointment (Protopic)
Oxytocin treatment
Filgrastim
Phase II ARRY-614 + nivolumab
Seroquel (quetiapine)
View Full List
CROs by country
Contract Research Organizations in Argentina
Contract Research Organizations in Bahrain
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Macedonia
Contract Research Organizations in Malta
Contract Research Organizations in Morocco
Contract Research Organizations in Papua New Guinea
Contract Research Organizations in Philippines
Contract Research Organizations in Russia
Contract Research Organizations in Taiwan
Contract Research Organizations in Turkmenistan
Contract Research Organizations in Uruguay
Contract Research Organizations in Vietnam
CRO list by country
CROs in Jordan
SGS
Arab Pharmaceutical Industry Consulting Co
MCT
Mesned CRO
All CROs in Jordan
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe